Immunoglobulin and T Cell Receptor Gene High-Throughput Sequencing Quantifies Minimal Residual Disease in Acute Lymphoblastic Leukemia and Predicts Post-Transplantation Relapse and Survival-Reference-Cited by-同舟云学术

Immunoglobulin and T Cell Receptor Gene High-Throughput Sequencing Quantifies Minimal Residual Disease in Acute Lymphoblastic Leukemia and Predicts Post-Transplantation Relapse and Survival

Published:2014-09 Issue:9 Volume:20 Page:1307-1313
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Logan Aaron C.,Vashi Nikita,Faham Malek,Carlton Victoria,Kong Katherine,Buño Ismael,Zheng Jianbiao,Moorhead Martin,Klinger Mark,Zhang Bing,Waqar Amna,Zehnder James L.,Miklos David B.

Funder

American Society of Hematology

National Cancer Institute

Stanford University Cancer Institute

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference37 articles.

1. Acute lymphoblastic leukemia: monitoring minimal residual disease as a therapeutic principle;Bruggemann;Semin Oncol,2012

2. Residual leukaemia after bone marrow transplant in children with acute lymphoblastic leukaemia after first haematological relapse or with poor initial presenting features;Bunin;Br J Haematol,2003

3. Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study;Conter;Blood,2010